Bridging the gap between technological excellence, available infrastructure, capacity and local uptake of technologies to tackle the challenge of diagnostic, treatment and prevention of respiratory tract infections (RTIs).
Lateral flow assays (LFAs) are widely used diagnostic tools known for their simplicity, speed, and versatility. This webinar will guide participants through the key stages of LFA development, from conceptualisation and design to optimisation and validation. Drawing on over two decades of expertise in rapid diagnostics, we will share insights into material selection, assay configuration, and troubleshooting common challenges. Whether you’re new to lateral flow development or seeking to refine your approach, this session offers practical strategies to enhance assay performance and reliability.
Join the HOLICARE Academy and register for this webinar by
clicking here !
Michael Johnson is a Senior Scientist within the innovative R&D group at GADx. With over 20 years of experience in developing novel rapid diagnostics, including 11 years at GADx, he is dedicated to advancing diagnostic technologies. His expertise lies in creating platforms to evaluate and develop new antibodies for rapid diagnostic tests. He is also focused on designing supersensitive, low-cost, and robust assays to address critical health challenges in low- and middle-income countries, with a particular emphasis on Malaria and other neglected tropical diseases.
Bridging the gap between technological excellence, available infrastructure, capacity and local uptake of technologies to tackle the challenge of diagnostic, treatment and prevention of respiratory tract infections (RTIs).
HOLICARE is funded by the European Commission as part of the Horizon Europe Research and Innovation Programme, under Grant Agreement Nº 101057596
© 2023 HOLICARE All Rights Reserved